Giuseppe G L Biondi-Zoccai

Summary

Country: Italy

Publications

  1. ncbi C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes
    Antonio Abbate
    Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    Semin Vasc Med 3:375-84. 2003
  2. ncbi Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis
    Giovanni Landoni
    Department of Cardiothoracic Anesthesia and Intensive Care, Universita Vita Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    J Cardiothorac Vasc Anesth 22:27-33. 2008
  3. ncbi Impact of impedance threshold devices on cardiopulmonary resuscitation: a systematic review and meta-analysis of randomized controlled studies
    Luca Cabrini
    Department of Anesthesia and Intensive Care, Universita Vita Salute San Raffaele, and Istituto Scientifico San Raffaele, Milan, Italy
    Crit Care Med 36:1625-32. 2008
  4. ncbi Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS)
    Enrico Romagnoli
    San Raffaele Scientific Institute, Milan, Italy
    Am Heart J 160:535-542.e1. 2010
  5. ncbi Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Largo A Gemelli 8, 00168 Rome, Italy
    Resuscitation 59:221-4. 2003
  6. ncbi Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis
    G G L Biondi-Zoccai
    Institute of Cardiology, Caholic University, Rome, Italy
    Minerva Cardioangiol 52:195-208. 2004
  7. ncbi Female gender, myocardial remodeling and cardiac failure: are women protected from increased myocardiocyte apoptosis?
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Rome Italy
    Ital Heart J 5:498-504. 2004
  8. ncbi Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials
    Giuseppe G L Biondi-Zoccai
    Istituto di Cardiologia Università Cattolica del Sacro Cuore Policlinico A Gemelli Largo A Gemelli, 8 00168 Roma
    Ital Heart J 4:271-80. 2003
  9. ncbi Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Rome, Italy
    Am Heart J 149:504-11. 2005
  10. ncbi Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials
    Giuseppe G L Biondi-Zoccai
    Invasive Cardiology, San Raffaele Hospital, and EMO Centro Cuore Columbus, Milan, Italy
    Int J Cardiol 100:119-23. 2005

Detail Information

Publications85

  1. ncbi C-reactive protein and other inflammatory biomarkers as predictors of outcome following acute coronary syndromes
    Antonio Abbate
    Department of Cardiovascular Medicine, Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    Semin Vasc Med 3:375-84. 2003
    ....
  2. ncbi Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis
    Giovanni Landoni
    Department of Cardiothoracic Anesthesia and Intensive Care, Universita Vita Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milan, Italy
    J Cardiothorac Vasc Anesth 22:27-33. 2008
    ..To determine the efficacy of fenoldopam in the prevention of acute renal failure, the authors performed a systematic review of randomized, controlled trials and propensity-matched studies in patients undergoing cardiovascular surgery...
  3. ncbi Impact of impedance threshold devices on cardiopulmonary resuscitation: a systematic review and meta-analysis of randomized controlled studies
    Luca Cabrini
    Department of Anesthesia and Intensive Care, Universita Vita Salute San Raffaele, and Istituto Scientifico San Raffaele, Milan, Italy
    Crit Care Med 36:1625-32. 2008
    ..This review provides an update on the impedance threshold device and underlines its effect on short-term survival...
  4. ncbi Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS)
    Enrico Romagnoli
    San Raffaele Scientific Institute, Milan, Italy
    Am Heart J 160:535-542.e1. 2010
    ..This study aimed to evaluate clinical safety and efficacy of different strategies for bifurcations treatment in a large observational real-world registry...
  5. ncbi Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? A meta-analysis
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Largo A Gemelli 8, 00168 Rome, Italy
    Resuscitation 59:221-4. 2003
    ..Evidence in humans is still limited and confidence intervals estimates too wide to reliably confirm or disprove results obtained in experimental animal settings...
  6. ncbi Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis
    G G L Biondi-Zoccai
    Institute of Cardiology, Caholic University, Rome, Italy
    Minerva Cardioangiol 52:195-208. 2004
    ..We thus systematically reviewed randomized trials comparing clopidogrel vs ticlopidine after coronary stenting...
  7. ncbi Female gender, myocardial remodeling and cardiac failure: are women protected from increased myocardiocyte apoptosis?
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Rome Italy
    Ital Heart J 5:498-504. 2004
    ....
  8. ncbi Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials
    Giuseppe G L Biondi-Zoccai
    Istituto di Cardiologia Università Cattolica del Sacro Cuore Policlinico A Gemelli Largo A Gemelli, 8 00168 Roma
    Ital Heart J 4:271-80. 2003
    ..We thus undertook a systematic overview of the randomized trials comparing stenting vs CABG in coronary artery disease...
  9. ncbi Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Rome, Italy
    Am Heart J 149:504-11. 2005
    ..We performed a metaregression to explore the impact of intracoronary stenting and aggressive antiplatelet treatment on the risk/benefit ratio of an early invasive approach...
  10. ncbi Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials
    Giuseppe G L Biondi-Zoccai
    Invasive Cardiology, San Raffaele Hospital, and EMO Centro Cuore Columbus, Milan, Italy
    Int J Cardiol 100:119-23. 2005
    ..Drug-eluting stents (DES) have been recently investigated, with favorable data for many devices, but comparative data are lacking. We thus performed an adjusted indirect comparison metaanalysis of DES...
  11. ncbi Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions
    John Cosgrave
    EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:1663-8. 2005
    ..Overall, the 2 available stent platforms had similar performance characteristics...
  12. ncbi Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 49:2320-8. 2007
    ..This study was designed to compare the outcomes of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) in a contemporaneous cohort of real-world patients...
  13. ncbi Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial
    Francesco Burzotta
    Institute of Cardiology, Catholic University, Rome, Italy
    J Am Coll Cardiol 46:371-6. 2005
    ..The aim of this study was to evaluate the use of a new manual thrombus-aspirating device in unselected patients with ST-segment elevation acute myocardial infarction (STEMI) undergoing urgent percutaneous coronary intervention (PCI)...
  14. ncbi Late restenosis following sirolimus-eluting stent implantation
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    Am J Cardiol 100:41-4. 2007
    ..In conclusion, late restenosis is an infrequent but real entity; its existence implies we should not discount the possibility of restenosis as the cause of symptoms that develop >1 year after sirolimus-eluting stent implantation...
  15. ncbi Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    Am Heart J 153:354-9. 2007
    ..Currently, little data are available on the management of drug-eluting stent (DES) restenosis. Drug resistance may play a role in its etiology...
  16. ncbi Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trials
    Francesco Burzotta
    Institute of Cardiology, Catholic University of the Sacred Heart, Via Prati Fiscali 158, 00141 Rome, Italy
    Int J Cardiol 123:313-21. 2008
    ....
  17. ncbi Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure
    Antonio Abbate
    Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    J Am Coll Cardiol 41:753-60. 2003
    ....
  18. ncbi Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents
    Pierfrancesco Agostoni
    San Raffaele Hospital, Milan, Italy
    Am J Cardiol 99:593-8. 2007
    ..Thus, late loss may not be a reliable marker of the true efficacy of these devices due to its complex and nongaussian distribution...
  19. ncbi Widespread myocardial inflammation and infarct-related artery patency
    Antonio Abbate
    Institute of Cardiology, Catholic University, Rome, Italy
    Circulation 110:46-50. 2004
    ....
  20. ncbi Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy
    Eur Heart J 27:540-6. 2006
    ....
  21. ncbi 17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease
    Flavio Airoldi
    Interventional Cardiology Unit, San Raffaele Hospital, Milan, Italy
    Am J Cardiol 96:664-7. 2005
    ..47). The mid-term clinical and angiographic outcomes did not indicate superiority of the 17-beta-E eluting stent over the control PC stent...
  22. ncbi Drug-eluting stent restenosis the pattern predicts the outcome
    John Cosgrave
    EMO Centro Cuore Columbus, Milan, Italy
    J Am Coll Cardiol 47:2399-404. 2006
    ..CONCLUSIONS: Similar to bare-metal stent data, the angiographic pattern of restenosis following DES implantation is prognostically important. Diabetes is a significant predictor of the pattern of restenosis in the DES era...
  23. ncbi Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials
    Francesco Burzotta
    Cardiology Institute, Catholic University of Sacred Heart, Rome, Italy
    Eur Heart J 30:2193-203. 2009
    ..Thus, we sought to assess these issues in a collaborative individual patient-data pooled analysis of randomized studies (study acronym: ATTEMPT, number of registration: NCT00766740)...
  24. ncbi Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI
    Enrico Romagnoli
    Institute of Cardiology, Catholic University, Largo A Gemelli 8, 00168 Rome, Italy
    Int J Cardiol 105:250-5. 2005
    ..c.) administration of a systemic bolus dose of abciximab during PCI may increase the efficacy of this antiplatelet drug. However, the effect of i.c. abciximab on coronary angiographic flow has been not clarified...
  25. ncbi A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. study
    Francesco Burzotta
    Institute of Cardiology, Catholic University, Rome, Italy
    Catheter Cardiovasc Interv 67:887-93. 2006
    ..Thus, interventional techniques able to reduce thrombus burden at the culprit vessel might improve final myocardial reperfusion...
  26. ncbi Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials
    Alberto Zangrillo
    Department of Anesthesia, Intensive Care, Universita Vita Salute San Raffaele, Milan, Italy
    J Cardiothorac Vasc Anesth 26:407-13. 2012
    ....
  27. ncbi The 'Open-Artery Hypothesis': new clinical and pathophysiologic insights
    Antonio Abbate
    Institute of Cardiology, Catholic University, Largo A Gemelli, 8, IT 00168 Rome, Italy
    Cardiology 100:196-206. 2003
    ..Limitations of ischemic left ventricular dilatation and myopathy could markedly reduce cardiovascular morbidity and mortality after acute myocardial infarction...
  28. ncbi Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Rome, Italy
    Int J Cardiol 94:105-10. 2004
    ....
  29. ncbi Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients
    Felicita Andreotti
    Institute of Cardiology, Catholic University, Largo F Vito, 00168, Rome, Italy
    Eur Heart J 27:519-26. 2006
    ..We conducted a specific meta-analysis of randomized trials comparing aspirin plus warfarin (A+W) with aspirin alone in such patients...
  30. ncbi Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI
    Maria De Vita
    Institute of Cardiology, Catholic University, Via B Barbiellini Amidei, 80, 00168, Rome, Italy
    J Invasive Cardiol 20:161-5. 2008
    ..Due to the high thrombus burden present in ST, the use of thrombus aspiration (TA) may enhance the angiographic results by limiting distal embolization...
  31. ncbi Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent era
    Pierfrancesco Agostoni
    S Raffaele Hospital, Vita e Salute University, Milan, Italy
    Am Heart J 151:682-9. 2006
    ....
  32. ncbi Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention
    Marzia Lotrionte
    Institute of Cardiology, Catholic University, Rome, Italy
    Am J Cardiol 100:1199-206. 2007
    ..In conclusion, a high clopidogrel loading dose (>300 mg) significantly reduces early ischemic events in patients scheduled for percutaneous coronary intervention...
  33. ncbi Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE)
    Giuseppe G L Biondi Zoccai
    Mediolanum Cardio Research, Milan, Italy
    Int J Cardiol 117:349-54. 2007
    ..Indeed, the TRUE Study, including as much as 115 ULM and 229 bifurcation interventions, should give important insights into the outcome of PES in such an unprecedented and challenging context...
  34. ncbi Appraising the effectiveness and safety of paclitaxel-eluting stents in over 1,000 very high-risk patients: overall results of the Taxus in Real-life Usage Evaluation (TRUE) registry
    Giuseppe M Sangiorgi
    EMO Centro Cuore Columbus, Milan, Italy
    EuroIntervention 3:333-9. 2007
    ..Conclusions: This registry, enrolling 1,065 high-risk patients treated with PES, confirms the satisfactory performance of this device, especially given the overall profile of enrolled subjects and the limited number of stent thromboses...
  35. ncbi Rationale for intracoronary administration of abciximab
    Enrico Romagnoli
    Department of Cardiovascular Disease, Catholic University, Campobasso, Italy
    J Thromb Thrombolysis 23:57-63. 2007
    ..On such basis, the present review aims to describe the pharmacological aspects as well as the available clinical data supporting the choice of intracoronary route of administration for abciximab...
  36. ncbi Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials
    Giovanni Landoni
    Department of Cardiothoracic Anesthesia and Intensive Care, Universita Vita Salute San Raffaele, Milano, Milan, Italy
    J Cardiothorac Vasc Anesth 21:502-11. 2007
    ..The authors performed a meta-analysis to investigate whether the cardioprotective effects of volatile anesthetics translate into decreased morbidity and mortality in patients undergoing cardiac surgery...
  37. ncbi Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era
    Giuseppe G L Biondi-Zoccai
    St. Raffaele Hospital, Milan, Italy
    Am J Cardiol 95:1466-8. 2005
    ..Such results may provide useful information to guide prevention of this complication...
  38. ncbi Spinal analgesia in cardiac surgery: a meta-analysis of randomized controlled trials
    Alberto Zangrillo
    Department of Anesthesia and Intensive Care, Universita Vita Salute San Raffaele, Milan, Italy
    J Cardiothorac Vasc Anesth 23:813-21. 2009
    ..The authors conducted a review of randomized studies to show whether there are any advantages in clinically relevant outcomes using spinal analgesia in patients undergoing cardiac surgery...
  39. ncbi Individual patient-data meta-analysis comparing clinical outcome in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention with or without prior thrombectomy. ATTEMPT study: a pooled Analysis of Trials on ThrombEc
    Maria De Vita
    Cardiology Institute, Catholic University of Sacred Heart, Rome, Italy
    Vasc Health Risk Manag 5:243-7. 2009
    ..Thus we have designed a collaborative individual patient-data meta-analysis which aimed to assess the long-term clinical outcome in STEMI patients randomized to percutaneous coronary intervention (PCI) with or without thrombectomy...
  40. ncbi Clinical manifestations of coronary aneurysms in the adult as possible sequelae of Kawasaki disease during infancy
    Quintino Parisi
    Institute of Cardiology, Catholic University of Rome, Rome, Italy
    Acta Cardiol 59:5-9. 2004
    ..The present reports highlight the potential clinical relevance of previously misdiagnosed KD in patients with ischaemic chest pain, low probability of atherosclerosis and coronary aneurysms...
  41. ncbi Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction
    Antonio Abbate
    Institute of Cardiology, Catholic Univeristy, Rome, Italy
    Circulation 106:1051-4. 2002
    ..These data may suggest that the post-AMI benefits observed with a patent IRA (the "open-artery hypothesis") may in part be due to reduced myocardial apoptosis...
  42. ncbi Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling
    Antonio Abbate
    Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy
    J Cell Physiol 193:145-53. 2002
    ....
  43. ncbi Treatment of mediastinitis using an open irrigation and delayed sternal reconstruction with a pectoralis major muscle flap
    Nicola Luciani
    Department of Cardiology and Cardiovascular Surgery, Catholic University, Rome, Italy
    Ital Heart J 4:468-72. 2003
    ..To date, the optimal treatment of mediastinitis is still controversial: the "closed wound" procedures and the "open wound" treatments are the two conventional modalities reported in the literature...
  44. ncbi Long-term effect of chronic oral anticoagulation: focus on coronary artery disease
    Marzia Lotrionte
    Institute of Cardiology, Catholic University, Rome, Italy
    Future Cardiol 5:259-71. 2009
    ..This review provides a succinct and updated appraisal of the long-term effects of chronic oral anticoagulation in the setting of coronary artery disease...
  45. ncbi New insights into molecular mechanisms of diffuse coronary ectasiae: a possible role for VEGF
    Marinica Savino
    Institute of Cardiology, Catholic University of the Sacred Heart, Largo A. Gemelli 8, 00168 Rome, Italy
    Int J Cardiol 106:307-12. 2006
    ....
  46. ncbi Ximelagatran/melagatran against conventional anticoagulation: a meta-analysis based on 22,639 patients
    L Testa
    Institute of Cardiology, Catholic University, Largo F Vito 1 00168 Rome, Italy
    Int J Cardiol 122:117-24. 2007
    ....
  47. ncbi Atherothrombosis, inflammation, and diabetes
    Giuseppe G L Biondi-Zoccai
    Institute of Cardiology, Catholic University, Rome, Italy
    J Am Coll Cardiol 41:1071-7. 2003
    ....
  48. ncbi Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence
    Amedeo Anselmi
    Department of Cardiovascular Sciences, Campus Biomedico University, Rome, Italy
    Eur J Cardiothorac Surg 25:304-11. 2004
    ..This review will provide an overview of the major studies about the link between ischemia, myocardial inflammation and apoptosis during and after CS, with particular regard to the markers and methods for apoptosis detection...
  49. ncbi Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis
    Luca Testa
    Institute of Cardiology, Catholic University, Largo F. Vito 1, 00168 Rome, Italy
    Eur Heart J 26:2000-6. 2005
    ....
  50. ncbi Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilo
    Marzia Lotrionte
    Division of Heart Failure and Cardiac Rehabilitation, Cardiovascular Department, Catholic University of the Sacred Heart, Rome, Italy
    Int J Cardiol 135:72-7. 2009
    ..Early detection at subclinical stage is pivotal to minimize the risk of overt cardiotoxicity. Liposomal anthracyclines have the potential for more selective uptake by cancer cells and reduced cardiac toxicity...
  51. ncbi What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel
    L Testa
    Department of Interventional Cardiology, S Ambrogio Clinical Institute, Milan, Italy
    QJM 103:367-77. 2010
    ..This review aims at exploring the development and available clinical data of this third-generation thienopyridine while discussing its practical implementation in routine practice...
  52. ncbi Comparison of the feasibility and effectiveness of transradial coronary angiography via right versus left radial artery approaches (from the PREVAIL Study)
    Francesco Pelliccia
    Dipartimento Universitario del Cuore e Grossi Vasi A Reale, 1 a Facoltà di Medicina e Chirurgia, Universita degli Studi di Roma La Sapienza, Rome, Italy
    Am J Cardiol 110:771-5. 2012
    ..In the contemporary real world, however, the left radial route is associated with shorter procedures and lower radiologic exposure than the right radial approach, independently of an operator's proficiency...
  53. ncbi EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention
    E Romagnoli
    Institute of Cardiology, Universita Cattolica del Sacro Cuore, Rome, Italy
    Heart 95:43-8. 2009
    ..Thus, we sought to assess the European System for Cardiac Operative Risk Evaluation (EuroSCORE) validity to predict in-hospital mortality after percutaneous coronary intervention (PCI). Design,..
  54. ncbi Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Am Heart J 153:587-93. 2007
    ..We performed a systematic review and meta-regression of randomized clinical trials comparing clopidogrel versus ticlopidine, focusing on clopidogrel front-loading...
  55. ncbi Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents
    Simon J Corbett
    EMO Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, Italy
    Eur Heart J 27:2330-7. 2006
    ..In contrast, just under half of restenosis in PES is the more severe non-focal pattern. Paradoxically, the majority of focal restenosis occurs at the proximal stent margin for both platforms...
  56. ncbi Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling
    Darryn L Appleton
    VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, Virginia, USA
    Catheter Cardiovasc Interv 71:772-81. 2008
    ....
  57. ncbi Percutaneous saphenectomy: a potentially dreadful complication of cutting balloon angioplasty in saphenous vein grafts
    Worawut Tassanawiwat
    Int J Cardiol 106:418-9. 2006
    ..This clinical vignette emphasizes the role of optimal backup in order to deploy life-saving devices and successfully manage life-threatening pericardial tamponade due to SVG rupture...
  58. ncbi Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?
    Mario Bollati
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:403-5. 2008
    ..This clinical vignette suggests that suboptimal drug-eluting stent deployment may be associated with stent thrombosis well after the traditional time frame of subacute thrombosis...
  59. ncbi Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials
    Antonio Abbate
    Virginia Commonwealth University VCU Pauley Heart Center, Richmond, Virginia 23298, USA
    J Am Coll Cardiol 51:956-64. 2008
    ....
  60. ncbi Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients
    Giuseppe G L Biondi-Zoccai
    Int J Cardiol 114:104-5. 2007
    ..66 [0.52-0.84], p=0.0008 for target lesion revascularization). Indeed, such combination of direct and indirect comparisons should also be envisaged to soundly and timely appraise the next generation of drug-eluting stents...
  61. ncbi Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents
    Imad Sheiban
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    Am J Cardiol 100:431-5. 2007
    ..No case of stent thrombosis was reported. In conclusion, this single-center experience suggests that percutaneous use of SESs to treat LM disease in unselected high-risk patients is safe and effective even 1 year after implantation...
  62. ncbi Comparison of different methods of measurement of aspirin resistance: using the appropriate statistic
    Marzia Lotrionte
    Eur Heart J 29:138; author reply 138-9. 2008
  63. ncbi Drawbacks of nonrandomized trials in acute coronary syndromes
    Giuseppe G L Biondi-Zoccai
    Am J Cardiol 97:151. 2006
  64. ncbi Preprocedural C-reactive protein for risk prediction before percutaneous coronary intervention (PCI): a European perspective
    Luigi M Biasucci
    Clin Chem 50:1492-4. 2004
  65. ncbi Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study
    Giuseppe G L Biondi-Zoccai
    Int J Cardiol 108:406-7. 2006
    ..These findings thus support the overall safety and effectiveness of ticlopidine after DES implantation, and also confirm the increased risk of late thrombosis when premature withdrawal of thienopyridines occurs...
  66. ncbi Improvement of cardiac function with parecoxib, a cyclo-oxygenase-2 inhibitor, in a rat model of ischemic heart failure
    Antonio Abbate
    Virginia Commonwealth University Pauley Heart Center, Richmond, VA 23233, USA
    J Cardiovasc Pharmacol 49:416-8. 2007
    ..To assess changes in cardiac function in animals with ischemic congestive heart failure (CHF) treated with a selective cyclo-oxygenase-2 (COX-2) inhibitor...
  67. ncbi Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?
    Pierfrancesco Agostoni
    Antwerp Cardiovascular Institute Middleheim, AZ Middelheim, Antwerp, Belgium
    Am J Cardiol 97:603-5. 2006
    ....
  68. ncbi The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus Taxus
    Giuseppe G L Biondi-Zoccai
    J Cardiovasc Med (Hagerstown) 7:2-4. 2006
  69. ncbi Keeping a high standard in quantitative analyses, meta-analyses, and systematic reviews
    Giuseppe G L Biondi-Zoccai
    Eur Heart J 28:516-7; author reply 517-8. 2007
  70. ncbi Left ventricular hypertrophy, apoptosis, and progression to heart failure in severe aortic stenosis
    Amedeo Anselmi
    Eur Heart J 26:2747. 2005
  71. ncbi Potential antiapoptotic activity of aldosterone antagonists in postinfarction remodeling
    Giuseppe G L Biondi-Zoccai
    Circulation 108:e26. 2003
  72. ncbi Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials
    Pierfrancesco Agostoni
    Department of Biomedical and Surgical Sciences, Section of Cardiology, University of Verona, Piazzale Stefani 1, 37126 Verona, Italy
    Eur Heart J 26:881-9. 2005
    ..To compare, by meta-analytical techniques, the clinical impact of bare-metal stenting vs. balloon angioplasty for the treatment of lesions in small coronary arteries...
  73. ncbi Right ventricular cardiomyocyte apoptosis in patients with acute myocardial infarction of the left ventricular wall
    Antonio Abbate
    Virginia Commonwealth University, Pauley Heart Center, Richmond, Virginia, USA
    Am J Cardiol 102:658-62. 2008
    ..91, p = 0.002 for RV free wall thickness). In conclusion, patients with cardiac remodeling after AMI had a significant increase in RV apoptosis even when ischemic involvement of the RV wall was not apparent...
  74. ncbi Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium
    Antonio Abbate
    Department of Medicine, Virginia Commonwealth University MCV Campus, Richmond, VA, USA
    Eur Heart J 26:2039-45. 2005
    ..It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium...
  75. ncbi A randomized trial comparing eptifibatide vs. placebo in patients with diffuse coronary artery disease undergoing drug-eluting stent implantation: design of the INtegrilin plus STenting to Avoid myocardial Necrosis Trial
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Turin, Italy
    J Cardiovasc Med (Hagerstown) 9:957-62. 2008
    ....
  76. ncbi Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
    Antonio Abbate
    Division of Cardiology VCU Pauley Heart Center, Virginia Commonwealth University, 1200 E Broad St, West Hospital, 10th Floor, East Wing, Room 1041, PO Box 980281, Richmond, VA 23298 0281, USA
    Circulation 117:2670-83. 2008
    ..The aim of the present study was to test the impact of an exogenous recombinant human interleukin-1 receptor antagonist (anakinra) in experimental acute myocardial infarction...
  77. ncbi Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis
    Michele Hamon
    Department of Radiology of the University Hospital of Caen, Caen, Normandy, France
    J Am Coll Cardiol 48:1896-910. 2006
    ..This study was designed to define the current role of multislice spiral computed tomography (MSCT) for the diagnosis of coronary artery disease (CAD) using a meta-analytic process...
  78. ncbi Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasound
    Gaston A Rodriguez-Granillo
    Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
    Am J Cardiol 99:5-10. 2007
    ..13 mm(3), 95% confidence interval -4.42 to 4.68, p = 0.96). In conclusion, statin therapy, particularly when achieving the target LDL level, appears to promote a significant regression of coronary plaque volume as measured by IVUS...
  79. ncbi Low-dose aspirin for stroke prevention
    Luca Testa
    Stroke 37:1356. 2006
  80. ncbi Potentials and pitfalls of clinical outcome research studies in cardiac surgery
    Giuseppe G L Biondi-Zoccai
    Eur J Cardiothorac Surg 29:855-6; author reply 856. 2006
  81. ncbi Recurrent angina after coronary revascularization: a clinical challenge
    Antonio Abbate
    Division of Cardiology, West Hospital, Virginia Commonwealth University VCU Pauley Heart Center, 1200 E, Marshall Street, PO Box 980036, Richmond, VA 23298 0036, USA
    Eur Heart J 28:1057-65. 2007
    ..This review attempts to summarize the most common causes of recurrent chest pain after coronary revascularization, to analyse the possible diagnostic approaches, and to discuss the potential treatment modalities...
  82. ncbi Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study
    Giuseppe G L Biondi-Zoccai
    Hemodynamics and Cardiovascular Radiology Service, Policlinico San Donato, Via Morandi 30, 20097 San Donato Milanese, Italy
    BMJ 332:202-9. 2006
    ..To appraise multiple systematic reviews on the same clinical topic, focusing on predictors and correlates of quality of reporting of meta-analysis (QUOROM) scores...
  83. ncbi Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat
    Stefania Straino
    VCU Pauley Heart Center, Virginia Commonwealth University, Richmond, VA 23298, USA
    J Cardiovasc Pharmacol 50:571-7. 2007
    ..The aim of the present study was to evaluate the effects of parecoxib, a selective COX-2 inhibitor, in an experimental AMI model in the rat...
  84. ncbi A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease
    Giuseppe G L Biondi-Zoccai
    Interventional Cardiology, Division of Cardiology, University of Turin, Corso Bramante 88 90, 10126 Turin, Italy
    Eur Heart J 27:2667-74. 2006
    ..We thus undertook a systematic review to appraise the hazards inherent to aspirin withdrawal or non-compliance in subjects at risk for or with CAD...
  85. ncbi The retrograde coronary approach for chronic total occlusions: mid-term results and technical tips & tricks
    Imad Sheiban
    Division of Cardiology, University of Turin, Turin, Italy
    J Interv Cardiol 20:466-73. 2007
    ..The retrograde approach is a novel but still incompletely described technique. We report our 5-year-long experience in retrograde percutaneous coronary intervention (PCI) for CTOs...